10 Jan by Vitaliy Dadalyan Some Aclaris Therapeutics (NASDAQ:ACRS) Shareholders Have Taken A Painful 94% Share Price Drop It is a pleasure to report that the Aclaris Therapeutics, Inc. (NASDAQ:ACRS) is up 31% in the last quarter. But that…
